Transgenomic Company Profile (NASDAQ:TBIO)

About Transgenomic

Transgenomic, Inc. is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies.

Industry, Sector and Symbol:

Sector: Medical
Industry: Scientific & Technical Instruments
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: TBIO
CUSIP:

Key Metrics:

Previous Close: $0.30
50 Day Moving Average: $0.3260
200 Day Moving Average: $0.5137
52-Week Range: $0.25 - $1.48
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -0.14
P/E Growth: 0.0000
Market Cap: $7.07M
Outstanding Shares: 23,547,000
Beta: 0.15

Profitability:

Return on Equity: -143.12%
Return on Assets: -35.73%

Debt:

Current Ratio: 0.10%
Quick Ratio: 0.10%

Additional Links:

Companies Related to Transgenomic:

Consensus Ratings for Transgenomic (NASDAQ:TBIO) (?)

Ratings Breakdown:	No ratings tracked in the last 12 months.
Consensus Rating:	N/A (Score: NaN)
Consensus Price Target:	N/A

Analysts' Ratings History for Transgenomic (NASDAQ:TBIO)

Show:

Date	Firm	Action	Rating	Price Target	Details
8/14/2015	Craig Hallum	Lower Price Target	Buy	$8.00

(Data available from 9/28/2014 forward)

Earnings History for Transgenomic (NASDAQ:TBIO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/10/2016
8/12/2016	Q216		($0.10)			View	Listen
5/24/2016	Q116		($0.10)			View	Listen
11/12/2015	Q315	($0.27)	($0.18)	$6.65 million	$4.00 million	View	Listen
8/13/2015	Q215	($0.41)	($0.30)	$7.10 million	$7.00 million	View	Listen
5/14/2015	Q115	($0.52)	($0.36)	$6.80 million	$6.51 million	View	Listen
4/15/2015	Q414	($0.56)	($0.77)	$6.20 million	$7.70 million	View	N/A
10/30/2014		($0.58)	($0.61)			View	N/A
5/7/2014		($0.47)	($0.60)			View	N/A
3/12/2014		($0.36)	($0.05)			View	N/A
8/6/2013	2Q13	($0.03)	($0.03)			View	N/A
5/8/2013	1Q13	($0.03)	($0.04)			View	N/A
3/13/2013	4Q12	($0.03)	($0.03)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Transgenomic (NASDAQ:TBIO)

Current Year EPS Consensus Estimate: $-1.4500 EPS
Next Year EPS Consensus Estimate: $-2.1400 EPS

Dividend History for Transgenomic (NASDAQ:TBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Transgenomic (NASDAQ:TBIO)

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 35.60%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
5/22/2014	Leroy C Kopp	Major Shareholder	Sell	413,050	$3.70	$1,528,285.00
10/2/2013	Leroy C Kopp	Major Shareholder	Buy	9,000	$0.39	$3,510.00

(Data available from 1/1/2013 forward)

Latest Headlines for Transgenomic (NASDAQ:TBIO)

Date	Headline
	Volume Buzzers on Charts: Novatel Wireless Inc. (NASDAQ:MIFI), Transgenomic Inc. (NASDAQ:TBIO) - Street Wise Report (press release) (blog) (NASDAQ:TBIO) streetwisereport.com - September 26 at 11:42 AM
	Hot News- CenturyLink, Inc. (NYSE:CTL), Transgenomic Inc. (NASDAQ:TBIO) - Seneca Globe (NASDAQ:TBIO) www.senecaglobe.com - September 26 at 11:42 AM
	TRANSGENOMIC INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TBIO) biz.yahoo.com - September 23 at 6:58 PM
	Transgenomic and Ventana Medical Systems Complete Data Sharing Agreement - Business Wire (press release) (NASDAQ:TBIO) www.businesswire.com - September 22 at 10:31 AM
	Transgenomic and Ventana Medical Systems Complete Data Sharing Agreement (NASDAQ:TBIO) www.publicnow.com - September 22 at 10:31 AM
	Penny Stock Investors Take an Interest in Transgenomic Inc. (NASDAQ:TBIO) - Duncan Research (NASDAQ:TBIO) www.duncanindependent.com - September 21 at 11:41 AM
	TRANSGENOMIC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; (NASDAQ:TBIO) biz.yahoo.com - August 29 at 7:36 PM
	Edited Transcript of TBIO earnings conference call or presentation 12-Aug-16 9:00pm GMT (NASDAQ:TBIO) finance.yahoo.com - August 26 at 7:22 PM
	TRANSGENOMIC INC Financials (NASDAQ:TBIO) finance.yahoo.com - August 25 at 7:57 PM
	ETF’s with exposure to Transgenomic, Inc. : August 17, 2016 (NASDAQ:TBIO) www.capitalcube.com - August 17 at 8:02 PM
	Transgenomic, Inc. :TBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:TBIO) www.capitalcube.com - August 16 at 7:49 PM
	Transgenomic, Inc. Reports Second Quarter 2016 Financial Results (NASDAQ:TBIO) www.biospace.com - August 15 at 8:03 PM
	HCP's Big Dividend And Its New QCP Risks (NASDAQ:TBIO) www.nasdaq.com - August 13 at 10:32 AM
	TRANSGENOMIC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:TBIO) biz.yahoo.com - August 12 at 7:52 PM
	Transgenomic Reports Second Quarter 2016 Financial Results (NASDAQ:TBIO) www.publicnow.com - August 12 at 7:52 PM
	Q2 2016 Transgenomic Inc Earnings Release - After Market Close (NASDAQ:TBIO) biz.yahoo.com - August 12 at 10:57 AM
	Stock Update on Transgenomic Inc. (NASDAQ:TBIO) - Duncan Research (NASDAQ:TBIO) www.duncanindependent.com - August 11 at 8:17 PM
	Transgenomic to Hold Second Quarter 2016 Results Conference Call on August 12, 2016 at 5:00 PM EDT (NASDAQ:TBIO) www.publicnow.com - August 10 at 8:15 PM
	VWR to Distribute Transgenomics ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO) www.cbs58.com - August 9 at 8:01 PM
	Transgenomic : VWR to Distribute Transgenomic’s ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO) www.4-traders.com - August 9 at 8:01 PM
	VWR to Distribute Transgenomic's ICEme Kits That Enable Liquid Biopsy-Based Cancer Research on Existing Platforms - Business Wire (press release) (NASDAQ:TBIO) www.businesswire.com - August 8 at 10:50 AM
	VWR to Distribute Transgenomic’s ICEme Kits that Enable Liquid Biopsy-Based Cancer Research on Existing Platforms (NASDAQ:TBIO) www.publicnow.com - August 8 at 10:50 AM
	Transgenomic Launches First Commercially Available CLIA Test for … (NASDAQ:TBIO) www.tmcnet.com - July 26 at 8:10 PM
	Transgenomic (TBIO) Announces Launch of New CLIA Assays (NASDAQ:TBIO) www.streetinsider.com - July 26 at 8:10 PM
	ETF’s with exposure to Transgenomic, Inc. : July 26, 2016 (NASDAQ:TBIO) www.capitalcube.com - July 26 at 1:01 PM
	Transgenomic (TBIO) Announces Launch of New CLIA Assays - StreetInsider.com (NASDAQ:TBIO) www.streetinsider.com - July 25 at 10:49 AM
	Transgenomic Launches First Commercially Available CLIA Test for Detection of EGFR C797S Mutations that Predict Resistance to 3rd Generation Kinase Therapies for Lung Cancer (NASDAQ:TBIO) www.publicnow.com - July 25 at 7:58 AM
	Transgenomic Licenses Commercial Rights To Its Long QT Syndrome DNA Testing Portfolio To LabCorp - Laboratory Network (NASDAQ:TBIO) www.laboratorynetwork.com - July 23 at 11:29 AM
	Transgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 9.95% - Consumer Eagle (NASDAQ:TBIO) www.consumereagle.com - July 23 at 11:29 AM
	Transgenomic : Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp (NASDAQ:TBIO) www.4-traders.com - July 21 at 8:05 PM
	Pre-Open Stock Movers 07/20: (PGNX) (TBIO) (GLBL) Higher; (ZFGN) (EVOK) (RYI) Lower (more...) - StreetInsider.com (NASDAQ:TBIO) www.streetinsider.com - July 20 at 10:38 AM
	Transgenomic Incorporated (NASDAQ:TBIO) Sellers Covered 37.88% of Their Shorts - Consumer Eagle (NASDAQ:TBIO) www.consumereagle.com - July 20 at 10:38 AM
	Transgenomic (TBIO) Licenses Long QT Syndrome DNA Testing Portfolio to LabCorp (LH) - StreetInsider.com (NASDAQ:TBIO) www.streetinsider.com - July 20 at 10:38 AM
	Transgenomic Inc (NASDAQ:TBIO) Move Down as Institutional Investors' Sentiment Improved - Press Telegraph (NASDAQ:TBIO) presstelegraph.com - July 15 at 6:41 PM
	Transgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Consumer Eagle (NASDAQ:TBIO) www.consumereagle.com - July 13 at 8:06 PM
	Is Major Move Coming For Transgenomic Inc After This Double Bottom Pattern? - Consumer Eagle (NASDAQ:TBIO) www.consumereagle.com - July 12 at 12:03 PM
	Transgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Press Telegraph (NASDAQ:TBIO) presstelegraph.com - July 2 at 7:11 PM
	Transgenomic Incorporated (NASDAQ:TBIO) Short Interest Decreased By 37.88% - Engelwood Daily (NASDAQ:TBIO) www.engelwooddaily.com - June 29 at 7:39 PM
	Transgenomic Incorporated (NASDAQ:TBIO) Short Interest Increased By 9.88% - Engelwood Daily (NASDAQ:TBIO) www.engelwooddaily.com - June 25 at 11:22 AM
	Transgenomic : Accelerates Commercialization of ICE COLD-PCR ICP amid Plans to Expand Cancer Product Line Ten-Fold (NASDAQ:TBIO) www.4-traders.com - June 23 at 8:26 PM
	Strong Buy Calls Count For Transgenomic, Inc. (NASDAQ:TBIO) At 1 - Investor Newswire (NASDAQ:TBIO) www.investornewswire.com - June 17 at 7:25 PM
	Investor News: Transgenomic Inc (NASDAQ:TBIO) faces Investigation - GroundReport (NASDAQ:TBIO) www.groundreport.com - June 17 at 7:25 PM
	Investor News: Transgenomic Inc (NASDAQ:TBIO) faces Investigation (NASDAQ:TBIO) www.groundreport.com - June 16 at 12:07 PM
	Transgenomic (TBIO) Announces Expansion of ICE COLD-PCR (ICP)-Powered Cancer Assays - StreetInsider.com (NASDAQ:TBIO) www.streetinsider.com - June 15 at 10:22 AM
	Transgenomic Accelerates Commercialization of ICE COLD-PCR (ICP) Amid Plans To Expand Cancer Product Line Ten-Fold (NASDAQ:TBIO) www.publicnow.com - June 14 at 7:39 AM
	Investigation of Transgenomic Inc (NASDAQ:TBIO) for Investors Announced - Digital Journal (NASDAQ:TBIO) www.digitaljournal.com - June 9 at 8:13 PM
	TRANSGENOMIC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Oblig (NASDAQ:TBIO) biz.yahoo.com - June 7 at 5:17 PM
	Transgenomic (TBIO) to Present New ICE COLD-PCR Tech Data at ASCO - StreetInsider.com (NASDAQ:TBIO) www.streetinsider.com - June 7 at 10:34 AM
	Transgenomic Releases New Data at ASCO 2016 Conference Confirming Concordance of ICE COLD-PCR (ICP) Liquid and Tissue Biopsies (NASDAQ:TBIO) www.publicnow.com - June 7 at 7:28 AM
	Transgenomic Releases New Data at ASCO 2016 Confirming Concordance of ICE COLD-PCR (ICP) Liquid and Tissue Biopsies (NASDAQ:TBIO) finance.yahoo.com - June 7 at 7:15 AM